# Phenotyping Chronic Obstructive Pulmonary Disease Through Principal Component Analysis: Identification of Clinical Clusters

## TL;DR

This study uses PCA to identify four distinct COPD patient clusters, helping to better understand and treat this heterogeneous disease.

## Contribution

The novel use of PCA to uncover clinically meaningful COPD phenotypes supports personalized treatment strategies.

## Key findings

- PCA identified four COPD clusters: chronic bronchitis, emphysema, COPD with asthmatic features, and non-exacerbator.
- The first two principal components explained 62% of the total variance in COPD patient data.
- Each cluster was associated with specific clinical features, highlighting COPD's heterogeneity.

## Abstract

Introduction

Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition with varied clinical presentations and prognoses. Identifying patient phenotypes is essential for developing personalized treatment strategies. Principal component analysis (PCA) is a statistical method that can be employed to uncover clinical clusters and gain insight into the relationships among different disease characteristics. This study aims to analyze COPD patient phenotypes using PCA and to identify the key clinical features influencing their distribution.

Materials and methods

This was a prospective, observational outpatient study involving 96 patients diagnosed with COPD. Data collected included demographic, clinical, spirometric, echocardiographic, laboratory, and functional parameters. PCA was applied to reduce data dimensionality and to identify the principal components underlying phenotype structure.

Results

The first two principal components accounted for 62% of the total variance, underscoring the clinical heterogeneity of COPD. Visualization of the PCA revealed four distinct clusters that align with recognized COPD phenotypes: chronic bronchitis, emphysema, COPD with asthmatic features (previously referred to as asthma-COPD overlap), and the non-exacerbator type. Each cluster was associated with specific clinical characteristics.

Conclusions

PCA enabled the identification of four distinct clinical clusters among COPD patients: bronchitis, emphysema, COPD with asthmatic features, and non-exacerbator. This approach helps clarify the relationship between clinical characteristics and supports a more personalized approach to treatment.